Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nicotine is a naturally occurring alkaloid found in tobacco and other plants of the nightshade family. It is a highly addictive stimulant and the primary psychoactive component responsible for tobacco dependence. Medically, nicotine is used as an aid to smoking cessation and for relief of withdrawal symptoms through various forms of nicotine replacement therapy (NRT), such as patches, gum, lozenges, inhalers, and nasal sprays[1][4]. Mechanistically, nicotine acts primarily as an agonist at nicotinic acetylcholine receptors (nAChRs) in the central and peripheral nervous systems. Activation of these ionotropic receptors leads to neuronal depolarization and increased release of neurotransmitters—most notably dopamine in reward pathways—which underlies its reinforcing effects[1][5][6]. At higher doses or with chronic use it can also have sedative properties. The addictive potential of nicotine makes it one of the most widely abused substances globally[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nicotine.